111, Inc. (YI)
| Market Cap | 488.12M |
| Revenue (ttm) | 1.01B |
| Net Income (ttm) | -72.84M |
| Shares Out | 82.87M |
| EPS (ttm) | -0.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 30 |
| Last Price | $5.89 |
| Previous Close | $6.05 |
| Change ($) | -0.16 |
| Change (%) | -2.64% |
| Day's Open | 5.94 |
| Day's Range | 5.81 - 6.24 |
| Day's Volume | 121,059 |
| 52-Week Range | 5.19 - 45.88 |
Looking to invest in America's top rival? Here are your best bets.
SHANGHAI, May 19, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and he...
Can't find bargains among U.S. stocks? Look abroad.
SHANGHAI, April 21, 2021 /PRNewswire/ – 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and h...
These companies are at the forefront of innovation in the healthcare sector, and their stocks are surprisingly affordable too.
SHANGHAI, March 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...
SHANGHAI, March 18, 2021 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), "), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine a...
SHANGHAI, March 17, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...
SHANGHAI, March 16, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and ...
SHANGHAI, Feb. 25, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and h...
These virtual care and online pharmacy platforms could make you healthy and wealthy.
Both companies boast triple-digit revenue growth, and both can offer investors big stock gains.
The Chinese healthcare platform is being compared to some successful U.S. peers.
SHANGHAI, Feb. 5, 2021 /PRNewswire/ -- On January 11, 2021, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients...
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and health...
111, Inc. (YI) CEO Junling Liu on Q3 2020 Results - Earnings Call Transcript
SHANGHAI, Nov. 19, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform committed to digitally connecting patients with medicine and healthcare ser...
SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") with Bayer Healthcare Co. Ltd. ("Bayer Healthcare"). ...
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical") signed a ...
SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) ("111") and Shanghai Uniondrug Information Technology Co., Ltd ("Shanghai Uniondrug") officially signed a strategic partne...
SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patients with dr...
SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc.
111, Inc. (YI) CEO Junling Liu on Q2 2020 Results - Earnings Call Transcript
SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc.
Completion of new capital injection in principal subsidiary Yao Fang Shanghai Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market 111 firmly committed to maintaining N...
SHANGHAI, July 31, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced...
111, Inc. (YI) CEO Junling Liu on Q1 2020 Results - Earnings Call Transcript
SHANGHAI, May 21, 2020 /PRNewswire/ --111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced i...
111, Inc. (YI) CEO Junling Liu on Q4 2019 Results - Earnings Call Transcript
111, Inc.'s (YI) CEO Junling Liu on Q3 2019 Results - Earnings Call Transcript
We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.
111, Inc. (YI) CEO Junling Liu on Q2 2019 Results - Earnings Call Transcript
111, Inc's (YI) CEO Junling Liu on Q1 2019 Results - Earnings Call Transcript
China's 111 Sees Boost From Healthcare Reform
One of China's leading online pharmacy and healthcare service providers says it will attract new partners as reforms take shape in the nation's healthcare market. 111 Inc. co-founder and Executive Chair...
About YI
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements... [Read more...]
| Industry Pharmaceutical Retailers | Founded 2010 |
| Stock Exchange NASDAQ | Ticker Symbol YI |
Financial Performance
In 2020, 111, Inc.'s revenue was 8.20 billion, an increase of 107.57% compared to the previous year's 3.95 billion. Losses were -456.53 million, -8.62% less than in 2019.
Analyst Forecasts
According to one analyst, the rating for 111, Inc. stock is "Strong Buy" and the 12-month stock price forecast is 15.98.